Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Nutex Health (NUTX) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Nutex Health (NUTX) over the last 10 years, with Q3 2025 value amounting to $101.6 million.

  • Nutex Health's Other Operating Expenses rose 11616.57% to $101.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $394.8 million, marking a year-over-year increase of 18504.82%. This contributed to the annual value of $241.8 million for FY2024, which is 160255.9% up from last year.
  • Latest data reveals that Nutex Health reported Other Operating Expenses of $101.6 million as of Q3 2025, which was up 11616.57% from $106.6 million recorded in Q2 2025.
  • Nutex Health's 5-year Other Operating Expenses high stood at $106.6 million for Q2 2025, and its period low was $73783.0 during Q1 2021.
  • For the 5-year period, Nutex Health's Other Operating Expenses averaged around $52.9 million, with its median value being $43.2 million (2022).
  • Its Other Operating Expenses has fluctuated over the past 5 years, first plummeted by 7112.05% in 2021, then surged by 4958823.85% in 2022.
  • Quarter analysis of 5 years shows Nutex Health's Other Operating Expenses stood at $39.8 million in 2021, then rose by 9.04% to $43.4 million in 2022, then tumbled by 67.32% to $14.2 million in 2023, then soared by 627.07% to $103.2 million in 2024, then decreased by 1.57% to $101.6 million in 2025.
  • Its last three reported values are $101.6 million in Q3 2025, $106.6 million for Q2 2025, and $83.4 million during Q1 2025.